In the present study, we have demonstrated the improvement of diabetic nephropathy in VASH2-deficient mice, and the inhibition of high glucose-induced extracellular matrix (ECM) protein production in cultured mesangial cells with suppressed VASH2 expression. The gene discussed is VASH2; the disease is diabetic kidney disease.